Skip to main content

Table 2 Estimated posterior odds ratios of patient characteristics associated with the intended adjuvant therapies, and relative weights between therapies (Continued)

From: Geographic variation in the intended choice of adjuvant treatments for women diagnosed with screen-detected breast cancer in Queensland

First screen diagnosed

    

Yes

1508

0.81 [0.69, 0.96]

0.79 [0.66, 0.94]

0.72 [0.63, 0.82]

No

4788

1.00

1.00

1.00

Surgery

    

Breast-conserving surgery

4255

1.00

1.00

1.00

Mastectomy

2009

0.03 [0.02, 0.03]

1.63 [1.40, 1.91]

0.86 [0.76, 0.98]

No surgery

15

0.15 [0.04, 0.44]

2.26 [0.76, 6.61]

0.86 [0.49, 1.44]

Unknown

17

0.18 [0.06, 0.47]

1.70 [0.64, 4.71]

1.10 [0.66, 1.89]

Relative weight of shared component

    

Radiotherapy

 

1.00

—

—

Chemotherapy

 

0.57 [0.36, 0.84]

1.00

—

Hormonal therapy

 

0.90 [0.68, 1.17]

1.59 [1.09, 2.47]

1.00

PPC

0.9993

  1. aAbbreviations: CrI Credible interval, N Number of patients, TRACT Travel to cancer treatment, IRSAD Index of relative socio-economic advantage and disadvantage, PPC Posterior predictive check